SUMMARY The ventricular weights in 43 patients with interstitial pulmonary fibrosis were retrospectively compared with those in 172 patients with emphysema and chronic bronchitis. The mean right ventricular weight of patients with interstitial pulmonary fibrosis and those with emphysema and chronic bronchitis was 855 g (SD 23-2) and 88-8 g (34 3), respectively. Thirty five patients (81 %) with interstitial pulmonary fibrosis had a right ventricular weight over 65 g compared with 124 (72%) of those with emphysema. Fifty three per cent of both those with interstitial pulmonary fibrosis and those with chronic bronchitis and emphysema had a right ventricular weight greater than 80 g. Differences between the two groups were not significant. These results suggest that the prevalence of right ventricular hypertrophy and pulmonary hypertension in interstitial pulmonary fibrosis is similar to that found in chronic bronchitis and emphysema.
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Cor pulmonale may be defined as "hypertrophy of the right ventricle resulting from diseases affecting the function and/or the structure of the lung, except when these pulmonary alterations are the result of diseases that primarily affect the left side of the heart or congenital heart disease".' The prevalence of right ventricular hypertrophy in chronic pulmonary diseases is poorly documented, except in chronic bronchitis and emphysema, where a prevalence at necropsy of 34% has been reported.2 Cor pulmonale is also a late complication of interstitial pulmonary fibrosis, but in this condition its prevalence is unknown. Right ventricular weight in interstitial pulmonary fibrosis, chronic bronchitis and emphysema chitis and emphysema. The corresponding weights for LV + S were 171-0 g (37 8) g and 189X6 (59 9)g for interstitial pulmonary fibrosis and chronic bronchitis and emphysema, respectively. The ratio LV + S/RV was 2 13 (0.63) in interstitial pulmonary fibrosis and 2 35 (0 77) in patients with chronic bronchitis and emphysema. Differences between the two groups were not significant.
Discussion
In any study designed to estimate the prevalence of a condition its definition is of paramount importance. In the context of cor pulmonale it is interesting that while the WHO definition requires the demonstration of right ventricular hypertrophy,' clinicians commonly await the appearance of oedema or overt right ventricular failure before diagnosing cor pulmonale in their patients. Although some pathologists define right ventricular hypertrophy as a right ventricular weight exceeding 65 g,2 others regard this figure as merely the upper limit of normal and do not consider unequivocal hypertrophy to be present unless the right ventricle weighs 80 g or more.3
Based on a right ventricle weight of 80 g, this study indicates that right ventricular hypertrophy is present in 53% of patients with terminal interstitial pulmonary fibrosis, an identical figure to that found in chronic bronchitis and emphysema. As it has been shown that an increased right ventricle weight at necropsy indicates pulmonary hypertension during life4 our data suggest that at the time of death the prevalence of pulmonary hypertension in patients with interstitial pulmonary fibrosis is similar to that in patients with chronic bronchitis and emphysema.
Although the anatomical changes of hypoxic cor pulmonale associated with chronic bronchitis and emphysema have been well documented,4 there is little published data on the morphology of the pulmonary vasculature in interstitial pulmonary fibrosis. In one necropsy study seven cases were investigated, of which four showed unequivocal right ventricular hypertrophy, together with a thick muscular media and intimal longitudinal muscular proliferation in pulmonary arteries and arterioles.5 More severely affected vessels showed intimal fibrosis and recanalisation of thrombi or total fibrous obliteration. In some instances there was a plexus of thin walled vessels, possibly representing the pulmonarysystemic anastomoses shown radiographically by Turner-Warwick.6 Muscular proliferation and fibrosis have been descibed by Dunnill,7 who also emphasised the common occurrence of thrombi without an obvious embolic source.
Predictions of pulmonary artery pressure from non-invasive physiological variables in patients with interstitial pulmonary fibrosis have been shown to be less accurate that those in chronic bronchitis and emphysema,8 suggesting that different mechanisms may be entailed. This hypothesis is supported by the work of Weitzenblum et al,9 who emphasise the dual roles of hypoxia and anatomical derangement by fibrosis in the development of pulmonary hypertension in patients with interstitial pulmonary fibrosis. A high proportion of patients dying with fibrosing alveolitis show hypertrophy of smooth muscle and hyperplasia of mucous glands in the larger bronchi, suggesting that in the later stages of the disease there is an obstructive element which could contribute to hypoxia.'o The relative importance of these factors is unknown.
This study has shown that cor pulmonale and pulmonary hypertension are equally prevalent in interstitial pulmonary fibrosis and chronic bronchitis and emphysema. Further haemodynamic and anatomical studies in patients with interstitial pulmonary fibrosis are necessary to investigate the pathogenesis of pulmonary hypertension and cor pulmonale in this disease. 
